Virus |
Avian influenza (H5N1) |
Adenovirus |
Beta 2 glycoprotein I (B2GPI) |
Coronavirus (corona virus) |
Crimean‐congo |
Cytomegalovirus (CMV) |
Dengue virus/dengue hemorrahic fever/dengue schock syndrome |
Ebola |
Epstein Barr (EBV) |
Hantavirus |
Hemorrhagic fever (hemorragic fever) |
Hepatitis A/B/C (HAV, HBV, HCV) |
Herpesvirus/herpes virus |
Herpes simplex virus (HSV) |
Human immunodeficiency virus (HIV) |
Influenza |
Junin (junin hemorrhagic fever) |
Lassa/lassa fever |
Marburg |
Mexican flu (H1N1) |
Parvovirus (B19) |
Respiratory tract infections |
Respiratory syncytial virus (RSV) |
Rhinovirus |
Severe acute respiratory syndrome (SARS) |
Varicella zoster (VZV) |
Viral hepatitis |
Yellow fever |
Coagulation |
Activated protein C (APC) |
Antiphospholipid antibodies/anticardiolipin antibodies/lupus anticoagulant |
Antithrombin (AT) |
Bleeding/hemorrhage/hemorrhage/bleeding complication |
Coagulation |
Coagulation factor/clotting factor |
d‐dimer |
Endothelial cell protein C receptor (EPCR) |
Factor XI |
Factor VIII |
Fibrin/fibrinogen |
Fibrinolysis |
Hemorrhagic/hemorrhagic complications |
Hemostasis/hemostasis |
Heparin cofactor II |
Heparan sulfate |
Plasmin–α2‐antiplasmin (PAP) |
Plasminogen activator inhibitor type I (PAI‐1) |
Platelets |
Protein C/protein S |
Prothrombin fragment 1 + 2 (F1 + 2) |
P‐selectin |
Soluble intercellular adhesion molecule (sICAM) |
Soluble vascular adhesion molecules (sVCAM) |
Tissue factor (TF) |
Tissue factor pathway inhibitor (TFPI) |
TF‐factor VIIa |
Thrombin–antithrombin (TAT) |
Thrombin‐activatable fibrinolysis inhibitor (TAFI) |
Thrombomodulin (TM) |
Thrombosis/thrombotic complication |
Tissue plasminogen activator (t‐PA) |
von Willebrand factor (VWF) |
Urokinase |